Thomas R. Cimato

Associate Professor
Department of Medicine
Buffalo VA Medical Center
United States of America

Academician Cardiology
Biography

Thomas R. Cimato care for patients with diagnoses across the spectrum of heart disease. His research is focused on new approaches to identifying patients at risk for heart attacks and strokes. He is the principal investigator of a pilot study (STEMI-HSC) to determine if the amount of hematopoietic stem cell mobilization in myocardial infarction predicts recurrent coronary events. The study is funded by the UB Translational Pilot Studies Fund, and my collaborators include other cardiology faculty and researchers at Roswell Park Cancer Institute (RPCI). He treats the patients with interventional cardiologists, heart rhythm specialists and heart surgeons. Education and Training: Postdoctoral Fellow, Stem Cell Biology, National Institutes of Health (2007), Fellowship, Advanced Heart Failure and Cardiac Transplant, Johns Hopkins School of Medicine (2006), Fellowship, Cardiovascular Medicine, Johns Hopkins School of Medicine (2006), Residency, Internal Medicine, University of Pennsylvania Health System (2002), PhD, Biochemistry, University at Buffalo (1999), MD, University at Buffalo (1999), BS, University at Buffalo, Cum Laude (1992). Professional Memberships: Member, International Society for Stem Cell Research (2006–present), Member, Heart Failure Society of America (2006–present), Member, American Society of Echocardiography (2006–present), Fellow, American Society of Nuclear Cardiology (2006–present).Presentations:"Hematopoietic Progenitors in Cancer and Heart Disease" UB Clinical and Translational Research Colloquium, University at Buffalo, Translational Research (2016), "Flow Cytometry Analysis of Hematopoietic Progenitors in Cancer and Cardiovascular Disease" International Society for Advancement of Cytometry, Webinar Series (2016), "Hematopoietic Progenitors in Cancer and Heart Disease" Roswell Park Cancer Institute Immunology Research Conference, Roswell Park Cancer Institute, Department of Immunology (2016), "Prevention of Heart Attack: Overview of the New Cholesterol Guidelines" SUNY at Buffalo-Dept Family Medicine, SUNY at Buffalo Sch of Medicine, Medical Grand Rounds (2013).

Research Intrest

Atherosclerosis and vascular biology, Cardiology, Critical Care Medicine

List of Publications
Cimato TR, Palka BA, Lang JK, Young RF. LDL cholesterol modulates human CD34+ HSPCs through effects on proliferation and the IL-17 G-CSF axis. PLoS One. 2013 Aug 26;8(8):e73861.
Lang JK, Cimato TR. Cholesterol and hematopoietic stem cells: inflammatory mediators of atherosclerosis. Stem cells translational medicine. 2014 May 1;3(5):549-52.
Cimato TR, Palka BA. Fractalkine (CX3CL1), GM-CSF and VEGF-a levels are reduced by statins in adult patients. Clinical and translational medicine. 2014 Dec 1;3(1):14.